0001267602-20-000033.txt : 20200303
0001267602-20-000033.hdr.sgml : 20200303
20200303162933
ACCESSION NUMBER: 0001267602-20-000033
CONFORMED SUBMISSION TYPE: 4/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190129
FILED AS OF DATE: 20200303
DATE AS OF CHANGE: 20200303
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Ashman Philip
CENTRAL INDEX KEY: 0001564990
FILING VALUES:
FORM TYPE: 4/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-34703
FILM NUMBER: 20682748
MAIL ADDRESS:
STREET 1: 6120 WINDWARD PARKWAY, SUITE 290
CITY: ALPHARETTA
STATE: GA
ZIP: 30005
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ALIMERA SCIENCES INC
CENTRAL INDEX KEY: 0001267602
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 200028718
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 6120 WINDWARD PARKWAY
STREET 2: STE 290
CITY: ALPHARETTA
STATE: GA
ZIP: 30005
BUSINESS PHONE: 678-990-5740
MAIL ADDRESS:
STREET 1: 6120 WINDWARD PARKWAY
STREET 2: STE 290
CITY: ALPHARETTA
STATE: GA
ZIP: 30005
4/A
1
wf-form4a_158327095625678.xml
FORM 4/A
X0306
4/A
2019-01-29
2019-01-31
0
0001267602
ALIMERA SCIENCES INC
ALIM
0001564990
Ashman Philip
6120 WINDWARD PARKWAY
SUITE 290
ALPHARETTA
GA
30005
0
1
0
0
Chief Operating Officer & SVP
Common Stock
8146
D
On January 31, 2019, the reporting person filed a Form 4 that inadvertently omitted the reporting person's restricted stock unit award reported on Form 4 on January 25, 2019 from the calculation of total amount of securities owned in Column 5. This omission carried through both transactions reported on such Form 4.
On November 14, 2019, after the close of business, the issuer effected a one-for-15 reverse stock split. The amount shown in Column 5 above reflects the amount that should have been reported in Column 5 of the original Form 4 after all transactions reported therein, after taking the reverse stock split into account. Without taking the reverse stock split into account, the amount shown in column 5 would have been 122,192 shares.
/s/ Philip Ashman
2020-03-03